Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer.

M Howell, R Lee, S Bowyer, A Fusi, P. Lorigan

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalLung Cancer
    DOIs
    Publication statusPublished - 16 Feb 2015

    Cite this